Stay updated on Epacadostat & Pembrolizumab in GIST Clinical Trial
Sign up to get notified when there's something new on the Epacadostat & Pembrolizumab in GIST Clinical Trial page.

Latest updates to the Epacadostat & Pembrolizumab in GIST Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange Detected- Recruitment status updated to 'No longer looking for participants', signaling that the study is no longer recruiting. - New help/navigation entries (How to Read a Study Record, Common Questions, How to Join a Study) were added, the header formatting was standardized from 'Intervention / Treatment' to 'Intervention/Treatment', and the revision note at the bottom was updated from v3.5.5 to v3.6.0.SummaryDifference0.6%

- Check16 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5, indicating a new page version. There are no visible edits to study details or user-facing content described in this change.SummaryDifference0.1%

- Check37 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4. This represents a small metadata update rather than substantive changes to the content.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page’s interface revision/version label was updated from v3.5.2 to v3.5.3, indicating a minor site release rather than any change to the clinical trial information.SummaryDifference0.1%

- Check66 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check80 days agoChange DetectedAdded the term 'Gastrointestinal stromal tumor' to the page content. Added a Resources entry linking to the Genetic and Rare Diseases Information Center.SummaryDifference0.2%

Stay in the know with updates to Epacadostat & Pembrolizumab in GIST Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat & Pembrolizumab in GIST Clinical Trial page.